CLINICAL_TRIALS
trial_result
· 2026-04-01
Clinical Trial Update: The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect [Phase 3]
Summary
Phase 3 adaptive platform trial in chronic kidney disease evaluating multiple agents for therapeutic effects is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The George Institute | Conditions: Chronic Kidney Diseases | Phase 3 | Status: RECRUITING